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Endometriosis is a local pelvic inflammatory process, frequently associated with infertility,
with altered function of immune-related cells in the peritoneal environment. Mast cells
are known to be key players of the immune system and have been recently involved in
endometriosis and in infertility, with their mediators directly suppressing sperm motility.
In this study, we evaluated the mast cell population and their mediators in the peritoneal
fluid of infertile patients with endometriosis and their impact on human sperm motility.
Peritoneal fluids, collected by laparoscopy from 11 infertile patients with endometriosis
and 9 fertile controls were evaluated for the presence of mast cells, tryptase levels
and their effect on sperm motility. Furthermore, an in vitro model of mast cells-sperm
interaction in peritoneal fluid was set up, using LAD2 cell line as a mast cell model, and
analyzed from a functional as well as a morphological point of view. Mast cell peritoneal
fluid population and its main mediator, tryptase, is more represented in endometriosis
confirming an involvement of these cells in this disease. Anyway it appears unlikely that
tryptase enriched peritoneal fluid, which fails to inhibit sperm motility, could contribute
to endometriosis associated infertility. Despite of this, sperm interaction with the mast
cell surface (LAD2) induced a significantly mast cell-degranulation response in the
peritoneal fluid from endometriosis which could directly modulate sperm function other
than motility. This evidence lead us to suppose that there is, between these elements,
an interrelationship which deserves further studies.
Keywords: endometriosis, infertility, mast cells, tryptase, sperm
INTRODUCTION
Endometriosis (EMS) is characterized by the presence and growth of endometrial tissue outside
the uterus. It is a common disease among women of reproductive age. Population-based studies
estimate a prevalence ranging between 1.8 and 3.3% in women aged 15–50 years (Morassutto
et al., 2016). Endometriosis is frequently associated with infertility, even if affected women have
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an ovulatory activity or a mechanical patency of the fallopian
tubes (Gupta et al., 2008; Máté et al., 2018).
The current consensus is that endometriosis is a local
pelvic inflammatory process with altered function of immune-
related cells in the peritoneal environment. There are recent
studies which support this theory, suggesting that the peritoneal
fluid of women with endometriosis contains an increased
number of activated macrophages that secrete various local
products, including growth factors, cytokines and possibly
oxidation products (Capobianco and Rovere-Querini, 2013),
implicating these factors in the development and progression of
endometriosis and endometriosis-associated infertility. Although
the contribution of specific immune cell subsets and their
mediators to the onset and the course of the inflammatory process
in endometrial lesions is still poorly understood, some evidence
suggests that mast cells (MC) are crucially involved. Mast cells
are known to be key players of the immune system, especially
during allergic reactions. However, increasing evidence supports
the involvement of MC also in the inflammatory process of
EMS. High numbers of degranulated MC have been found in
endometriotic lesions (Konno et al., 2003; Kempuraj et al., 2004;
Sugamata et al., 2005; Anaf et al., 2006; Kirchhoff et al., 2012;
Paula et al., 2015). Of note, this was not the case at unaffected
sites of the peritoneum or eutopic endometrial tissue from EMS
patients or healthy controls. Additionally, it has been shown
that stem cell factor (SCF), the major growth differentiation and
chemoattractant factor for MC, is found in higher concentrations
in the peritoneal fluid (PF) of EMS patients (Osuga et al., 2000).
Despite the possible MC role in the onset and/or the course of
the pelvic inflammatory process of endometriosis, neither the
amount of MC nor the level of their mediators has been evaluated
in EMS-peritoneal fluid to the best of our knowledge.
Endometriosis has been also associated with infertility even
in its early stages (Zondervan et al., 2018) before adhesion
or anatomic distortion take place. The exact mechanism of
endometriosis-associated infertility is not fully understood,
although many possible causes have been suggested, among them
the potential negative effects of cytokine-rich peritoneal fluid
(flushing the tubal and endometrial environment) on sperm
function (impairment of acrosome reaction and impairment
of sperm motility) (Gupta et al., 2008; Broi et al., 2019).
Since in humans there are no selective barriers separating the
Fallopian tubes and the peritoneal cavity, PF can be present
in the fertilization milieu (Harper, 1988). Although changes
in PF volume, cell concentration, hormones, growth factors,
cytokines and possibly free oxygen radicals production have been
well characterized in endometriosis (Oral et al., 1996; Bedaiwy
and Falcone, 2003; Bedaiwy et al., 2007; Nishida et al., 2011;
Rižner, 2015), data about the effect of this fluid on sperm
function are still controversial (Broi et al., 2019). Most of these
studies suggest that substances found in the peritoneal fluid
of patients with endometriosis could contribute to infertility
through impairment of both sperm function and motion kinetics
(Drudy et al., 1994; Zullo et al., 1994; Aeby et al., 1996; Oral
et al., 1996; Liu et al., 2000; Luo et al., 2008; Xu et al., 2008;
Mansour et al., 2009). However, other studies reported no adverse
effect of PF in patients with endometriosis on sperm motility
parameters, suggesting that peritoneal fluid in these patients
cannot contribute to infertility (Chen et al., 1997; Sharma et al.,
1999). Interestingly human recombinant tryptase, the main MC
product in all human MC, including those found in the female
genital tract (Yamanaka et al., 2000; Sivridis et al., 2001), has been
shown to reduce human sperm motility in vitro (Weidinger et al.,
2003), thus being a good candidate factor for influencing sperm
fertilizing ability.
In this study, we evaluated for the first time the amount
of MC and their main mediator (tryptase) in the peritoneal
fluid of infertile patients with endometriosis and their impact
on human sperm motility. Furthermore we evaluated mast cell-
sperm interaction in an in vitro model by using a human mast
cell line (LAD2).
MATERIALS AND METHODS
Patients for PF Collection
Twenty women undergoing either diagnostic or operative
laparoscopy at the Institute for Maternal and Child Health,
IRCCS Burlo Garofolo, Trieste, Italy were enrolled in a case-
control study. The study was reviewed and approved by
the Ethical Committee of the Institute for Maternal and
Child Health IRCCS Burlo Garofolo, Trieste, Italy (Prot.
1197/2015). Informed consent for participation in the study was
obtained from all women.
The study group (EMS group) consisted in total of 11
infertile women, diagnosed with moderate/severe endometriosis
(stage III-IV, n = 9) and minimal/mild endometriosis (stage
I-II, n = 2) according to the revised criteria of the American
Society for Reproductive Medicine ASRM (Canis et al., 1997).
They had normal ovulation and no other identifiable female
causes of infertility.
The control group (C group) consisted of a total of 9 fertile
women, without endometriosis, subjected to laparoscopy to
remove leiomyoma. Medical history and white blood cell count
(WBC) were recorded for all the patients.
PF Collection and Cytological Evaluation
Laparoscopy was performed, and all obtainable peritoneal fluid
in the pouch of Douglas was aspirated (by a suction unit through
a Teflon catheter) immediately after entering the abdominal
cavity and collected in sterile plastic tubes. Blood-free samples
were immediately transported to the laboratory where total
cell numbers were counted (Coulter, Miami, FL, United States)
and differential cell counts carried out using an optical
microscope on Diff-Quik System (Medion Diagnostics, Gmbh,
Düdingen, CH) and Toluidine Blue stained cytospin specimens
(Cytospin 2, Shandon Inc., Pittsburgh, PA, United States) on
by cytospin preparations after staining with Diff-Quick (Medion
Diagnostics, Dudingen, Switzerland). Subsequently, 1 mL of PF
was centrifuged (10 min, 600 g), filtered through a 0.22-µL
membrane (Millipore, Bedford, MA, United States) and stored
at −80◦C until used (<12 months). The remaining volume of
PF (at least 5 mL) was processed for cell blocks preparation by
using 10% alcohol–formalin as a fixative agent as described by
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Shivakumarswamy et al. (2012). After paraffin embedding 3 µm
thickness serial sections were prepared from this cell block and
stained immunohistochemically for tryptase (see below).
One of the main advantages of the cell block technique
is to obtain multiple sections for conventional stains and
immunohistochemistry (Shivakumarswamy et al., 2012).
Diagnostic sensitivity may be improved when cytology and cell
block preparation are used in tandem.
Immunocytochemical Staining for
Tryptase
Immunohistochemistry was performed on formalin-fixed,
paraffin-embedded cell block sections 3 µm thin using
Ultravision Quanto Large Volume Detection System HRP
Polymer (Bio Optica, Milan, Italy) pre-treated with Dewax and
HIER Buffer H, pH 8. The sections were incubated for 30 min,
at RT Temperature with anti Mast Cell Tryptase monoclonal
antibody (15-MOB347 – Bio Optica Milan, Italy) diluted 1:600
in Thermo Scientific Antibody Diluent OP Quanto (Cat. #
TA-125-ADQ). The primary antibody was omitted in negative
controls (Figure 2).
Finally, the sections were incubated for 10 min with 3,3′
Diaminobenzidine chromogen (DAB – Dako Milan, Italy)
and Mayer Hematoxylin to nuclear counterstain. Slides were
scanned by D-Sight Microscope and Scanner (A. Menarini
Diagnostic S.r.l. – Firenze, Italy), then analyzed by VISIA
Imaging S.r.l. software.
Protein Content
The PF protein content was quantitated with the Bradford
method (Bradford, 1976) using bovine-serum-albumin (BSA) as
standard and expressed in mg/mL.
Tryptase Concentration and Enzymatic
Activity
Tryptase, a tetrameric serine proteinase, is the major component
of mast cell granules, and comprises up to 20% of the total
protein of mast cells derived from lung, colon and skin
tissue (Schwartz and Bradford, 1986; He and Xie, 2004).
A colorimetric assay was used to determine the enzymatic activity
of tryptase in the PF samples both from patients and controls
(and LAD2 supernatants, see below) as previously described
(Borelli et al., 2018). The assay is based on spectrophotometric
detection of the chromophore p-nitroaniline (pNA) (Sigma-
Aldrich, United States) after cleavage from the labeled substrate
tosyl-gly-pro-lys-pNA. The free pNA was quantified using a
microtiter plate reader at 405 nm (Biotek Instruments Inc).
Samples were assayed in triplicate, and tryptase activity was
expressed in (arbitrary unit of absorbance/mL) AU/mL.
Tryptase (Enzyme-Linked Immunosorbent Assay (ELISA)
(USCN, Life Sciences Inc) immunoassay kit was used to
determine the concentration of tryptase in PF samples and pools
both from patients and controls. The assays were performed
according to the manufacturer’s instructions and the results
referred to a calibration curve expressed in ng/mL. Samples were
assayed in triplicate.
β-Hexosaminidase Enzyme Activity
β -hexosaminidase (β -hexo), another typical marker of
mast cell granules, was assayed spectrophotometrically by the
hydrolysis of 4-nitrophenyl N-acetyl-β-D-glucosaminide (Sigma-
Aldrich, United States) as previously described (Gri et al.,
2008; Medic et al., 2008). Samples were assayed in triplicate
and β -hexo activity was expressed in (arbitrary unit of
absorbance/mL) AU/mL.
Semen Samples: Isolation of Motile
Sperms
Fresh semen was collected (at the Assisted Reproduction Unit
of the Institute for Maternal and Child Health IRCCS Burlo
Garofolo and University of Trieste) from healthy subjects (n = 19,
mean age + SD: 39.6 ± 7.3 years) who had given informed
consent and had no history of diseases related to infertility. After
complete liquefaction, the ejaculates were analyzed according
to the standard semen parameters of the World Health
Organization (WHO laboratory manual for the examination
and processing of human semen, fifth edition. World Health
Organization [WHO], 2010). Motility was determined by manual
counting of at least 200 sperms observed under 400× phase
contrast optics.
A leukocyte count was carried out by using standard
peroxidase test, as described in the WHO laboratory manual.
All subjects were asymptomatic for genitourinary infections.
Only ejaculates with <1 × 106 white blood cells/mL, total
motility (World Health Organization [WHO], 2010: >40%) and
progressive motility (World Health Organization [WHO], 2010:
>32%) were used for the experiments.
For isolation of motile sperms, samples were processed using
the swim-up technique to eliminate dead spermatozoa and other
cells, including bacteria and leukocytes (Ricci et al., 2009). This
methodology is based on the active movement of spermatozoa
from the prewashed cell pellet into an overlaying medium.
Ejaculates were washed (centrifuged at 500 g for 10 min) and
resuspended in Human Tubular Fluid medium (HTFM, Irvine
Scientific, United States), containing 0.05% BSA. The supernatant
was discarded, the pellet was suspended in pre-warmed 0,5 mL
of HTFM. The pellet was gently over-layered with HTFM in
the tube, inclined at 45◦ and kept at 37◦C for 45–60 min.
A sterile Pasteur pipette was used to remove the supernatant
containing > 95% actively motile sperms whose concentration
ranged from 20 to 30× 106/mL.
Effect of Peritoneal Fluid on Human
Sperm Viability and Motility
Motility-enriched sperm samples (N = 19) were incubated in
HTFM containing 0.05% BSA (as negative control) or peritoneal
fluid in the ratio 1:4 (125 µL sperm samples and 500 µL
PF). For the seek of simplicity we preferred to evaluate many
fold peritoneal fluid pools than the single PF, accordingly, a
pool of peritoneal fluids was prepared from either groups by
mixing equal volumes of fluid samples taken from patients
with endometriosis.
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Sperm viability [Eosin-Nigrosin staining technique (Björndahl
et al., 2003)], total and progressive motility variables were
evaluated at 0, 3 (Weidinger et al., 2003) and 24 h (Mansour
et al., 2009) by manual counting of sperm observed under phase
contrast microscopy.
After 3 h no significant difference in viability was observed in
comparison with starting conditions (after swim up, T0), while
after 24 h viability was significantly decreased with respect to
T0, in the presence of HTFM, of peritoneal fluid from both
women with endometriosis and control patients (p < 0.05),
but no difference was observed when comparing viability of
spermatozoa incubated for 3 h or 24 h in either PF-C or
PF-EMS, to that of sperm incubated for the same period in
HTF medium alone (Figure 3).
LAD2 Human Mast Cell Line
The human MC line LAD2 was kindly provided by Prof. Carlo
Pucillo (Department of Medicine Medical Area, University of
Udine, Udine, Italy). The cell line was established from bone
marrow aspirates of a patient with MC sarcoma leukemia and
is closely related to hMC (Kirshenbaum et al., 2003). This cell
line has been widely used as a suitable model for analyzing mast
cell functions particularly degranulation and cytokine secretion
(Gage et al., 2009; Chan et al., 2014; Ramis et al., 2015)
suggesting that they are endowed with a well-defined secretory
apparatus and can be used to investigate the mechanism of
activation of their secretory pathways. Furthermore LAD2 have
increased expression of tryptase, which represent the mast cell
mediator of interest in our study, with respect to other human
mast cell line HMC-1 (Kanerva et al., 2009; Guhl et al., 2010;
Rådinger et al., 2010).
LAD2 cells were grown in serum-free medium StemPro-
34 (Gibco, Grand Island, NY) supplemented with 2 mM
L-glutamine (Gibco), 1% penicillin-streptomycin (Gibco), and
100 ng/mL human stem cell factor (PeproTech Inc., Rocky Hill,
NJ, United States) in a humidified atmosphere of 5% CO2 in air
at 37◦C. LAD2 were periodically tested for c-Kit expression on
the cell surface by flow cytometry (FACScan, Becton Dickinson,
San Diego, CA, United States). LAD2 cells were suspended at
1–2× 106/mL in Tyrode’s buffer containing 0.02% BSA (TyB).
In vitro Experimental Model of
MC-Sperm Interaction in the Peritoneal
Environment
LAD2 cells were incubated (30 min at 37◦C) with or without
highly motile sperms (1:3–5 ratio of cells to sperms), in Tyrode’s
buffer containing 0.02% BSA (TyB) or in the presence of 10% pool
PF-EMS or PF-C, then spun down at 250 × g for 7 min. With
the aim of evaluating if sperm represents a secretory stimulus for
MC, supernatants (SN) and pellets obtained after centrifugation
were evaluated for tryptase and β-hexo activity (degranulation
assay, see below).
Degranulation Assay
Tryptase and β-hexo activity (degranulation assay) were
evaluated in the supernatant (SN) and pellets using as enzyme
substrates, tosyl-gly-pro-lys-p-nitroanilide (0.25 mM final
concentration) for tryptase (see above) and 4-nitrophenyl
N-acetyl-β-D-glucosaminide (0.5 mM final concentration) for
β-hexo [as previously described (Gri et al., 2008; Medic et al.,
2008)]. The enzymatic activity was measured in an ELISA
reader (Bio-tek instruments INC) at 450 nm. The extent of
degranulation was calculated as the percentage of free pNA
(for tryptase) or 4-p-nitrophenol (for β-hexo) absorbance in
the supernatants taking the sum of the activities found in the
supernatants and in cell pellets solubilized in hexadecyl trimethyl
ammonium bromide (CTAB) (Sigma-Aldrich, United States)
0.05%, as 100%. Of note, we choose mainly β-hexo activity as
a marker of LAD2 degranulation since tryptase activity in PF
was too high and covered up the secretory response of LAD2.
4-p-nitrophenol absorbance values were adjusted subtracting the
β-hexo activity of sperms, PF-EMS and PF-C alone. A positive
control was obtained by cell stimulation with compound 48/80
(10 µg/mL final concentration), a well-known cationic mast cell
stimulating agent, for 30–60 min.
SEM Analysis of MC-Sperm Interaction
At the end of the incubation carried out for the degranulation
assay, two hundred microliters of the cell suspension (see
paragraph In vitro experimental model of MC-sperm interaction
in the peritoneal environment) were diluted with PBS (Dulbecco’s
modified phosphate buffered saline (PBS) (Sigma-Aldrich,
United States) and placed on a poly-L-lysine-coated glass
coverslip (18 mm diameter) (Menzler Glasser). The immobilized
cells were allowed to adhere to the coverslip over a 30-min
incubation period on ice. The supernatant was decanted, and
adherent cells were fixed in 2% glutaraldehyde PBS pH 7.4
at room temperature for 30 min. Fixation was followed by
rinsing in PBS and then dehydration through graded ethanols.
Samples were transferred to a critical point dryer (Bal-Tec; EM
Technology and Application, Furstentum, Liechtenstein) in 100%
ethanol and dried through CO2. Coverslips were mounted on
aluminum sample stubs and gold coated by sputtering (Edwards
S150A apparatus, Edwards High Vacuum, Crawley, West Sussex,
United Kingdom).
Cells were observed under both low (X 2,000–4,000) and
high (X 35,000–40,000) magnification and representative areas
were photographed. SEM micrographs are acquired by a Leica
Stereoscan 430i scanning electron microscope (Leica Cambridge
Ltd., Cambridge, United Kingdom). In each specimen prepared
from two different experiments more than 100 SEM fields,
including more than 600 LAD2s, were scored for the presence
of adherent sperms. The site of sperm-LAD2 interaction,
head/midportion (HM) or tail, was also specified.
Statistical Analysis
Statistical analysis was performed using Graph Pad Prism
(Graph Pad Software Inc., La Jolla, CA, United States). The
data (levels of blood parameters, PF cellular, and soluble
parameters, number of interacting LAD2 and number of
LAD2-interacting sperms and the percentage of degranulation)
are presented as mean ± Standard Error (SE) or Standard
Deviation (SD) (accordingly to the number of the sample
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scored). The Kolmogorov–Smirnov test was applied to assess
the normality of the studied data. Independent samples Student
t-test (unpaired) was used to compare data between the two
groups. Kruskal–Wallis test was used to evaluate differences
in spermatozoa parameters and, when statistically significant
differences were present, Dunn’s post hoc was used to individuate
group differences. In all instances, the level of significance for
statistical analysis was set at 5% (p < 0.05). Power analysis was
made using G∗Power software (Faul et al., 2007).
Power analysis was performed to assess feasibility of the
study: considering effect size = 1.15 and a = 0.05, power is
equal to 0.79, indicating that highly probable to find statistical
significant differences.
RESULTS
Blood Cell Counts and Peritoneal Fluid
Characterization of the Cellular
Components
Table 1 shows white blood counts performed before surgery.
The analysis of blood counts showed no statistically significant
difference in the number of total circulating leukocytes and
different leukocyte subpopulations between the two groups,
except that for basophilic granulocytes, whose relative percent
(compared to total leukocytes) was significantly lower (p = 0.021)
in the study group (mean ± SD: 0.54 ± 0.23) as compared to the
control group (mean± SD: 0.87± 0.35).
Table 2 shows the data related to the characteristics of
peritoneal fluid of the study group and the control group: volume
(mL); cell concentration (expressed in 106cells/mL); total cells
(106cells) and percentages for different leukocyte populations
FIGURE 1 | Representative images of cytocentrifuged smears of PF (EMS)
stained with Diff-Quick (a) and with Toluidin blue (TB) (b). Mast cells/basophils
are indicated by the arrows. Original magnification 1,000×. Scale
bars = 10 µm.
evaluated on cytocentrifuged samples of peritoneal fluid stained
using the Diff-Quick (DQ) (Figure 1a). To evaluate specifically
the population of MC the Toluidin Blue (TB) staining (Figure 1b)
was also performed and the results expressed as % of TB positive
cells (Table 2). There were no significant differences (p = 0.158)
neither between the volumes of the PF (mL) in the study group
(mean ± SD: 10.1 5.7; n = 11) and control groups (mean ± SD:
8.7 ± 3.5; n = 9), nor between the total cell count (expressed in
106 cells/mL) of the PF in the study group (1.6 ± 1.3; n = 11)
and the control group (1.7 ± 1.3; n = 9). Furthermore, the PF
counts (performed on Diff-Quick stained PF cytocentrifugates)
show no statistically significant difference in the percentage of
different subpopulations between the two groups with except of
neutrophils. As expected (Wang et al., 2018) the percentage of the
latter cells resulted significantly increased on the average.
Table 2 also shows the data related to the MC counts
evaluated on PF cytocentrifugates stained using TB, which
TABLE 1 | Demographic and clinical characteristics of patients in the study group: infertile women with endometriosis (EMS, N = 11) and control group: fertile women
without EMS (C, N = 9).
Blood (CBC, complete blood count)
Leukocytes
Age (years) (106/mL) Neut % Lymph % Mono % Eos % Bas %
Control (C) group (n = 9) 38.4 ± 6.1 7.9 ± 2.3 58.1 ± 8.9 30.3 ± 6.3 4,8 ± 0.9 3.9 ± 2.5 0.87 ± 0.35
Study (EMS) group (n = 11) 32.3 ± 4.9 6.6 ± 0.9 54.0 ± 6.6 34.2 ± 5.9 6.5 ± 2.4 3.0 ± 1.3 0.54 ± 0.23
Statistical analysis ns ns ns ns ns ns p = 0.021
Neut, neutrophils; Lymph, lymphocytes; Mono, monocytes; Eos, eosinophils and Bas, basophils. Values are the mean ± SD. Statistical analysis: Student t-test.
TABLE 2 | Cytological peritoneal fluid characterization in the study and control group.
Diff Quick stain TB
Vol PF (mL) 106 cells/mL M8/mono % Lymph % Neut % Eos % Meso % MC/baso
Control (C) Group (n = 9) 8.7 ± 3.5 1.7 ± 1.3 73.0 ± 10.4 16.0 ± 8.5 8.6 ± 4.5 1.1 ± 0.5 1.3 ± 0.8 0.5 ± 0.5
Study (EMS) Group (n = 11) 10.1 ± 5.7 1.6 ± 1.3 56.3 ± 13.4 14.1 ± 10.0 24.6 ± 7.0 2.5 ± 3.8 2.5 ± 5.6 2.8 ± 3.2
Statistical Analysis ns ns ns ns p < 0.05 ns ns ns
Neut, neutrophils; Lymph, lymphocytes; M8/Mono, macrophages/monocytes; Eos, eosinophils; Bas, basophils; MC, mast cells and Meso, mesothelial like cells; TB,
toluidine blue; n, patient number. Values, reported as percentage of total cell counted (always more than 200), are the mean ± SD. Statistical analysis: Student t-test.
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FIGURE 2 | Representative images of immunohistochemical analysis for
tryptase on cell blocks’ sections. (a) Two tryptase positive cells (from the EMS
study group) (arrows). (b) Negative control (primary antibody omitted). LAD2
cells in (c) represent a positive maker control for tryptase, in (d) the negative
control (primary antibody omitted) is shown. Original magnification 1,000×.
Scale bars = 10 µm.
makes recognizing MC more easy (EMS vs. C mean % ± SD:
2.8 ± 3.2 vs. 0.5 ± 0.5 p = 0.616). MC population is reduced
on the average in the control group, but these values were not
significantly different.
To clarify the results obtained with the cytocentrifugates the
remaining volume of PF was fixed in formalin (4%) and cell
blocks were prepared. Serial sections (3 µm) obtained from these
cell-blocks were processed for immunohistochemical analysis for
tryptase, a specific MC marker (Figures 2a,b), using LAD2 cells as
a positive marker control (Figures 2c,d). The results, expressed as
percentage of tryptase positive cells on total cells counted showed
that: the study group is characterized by a percentage of tryptase-
positive cells (MC) significantly (p = 0.044) higher (mean %± SD:
1.2± 0.6; n = 11) compared to the control group (mean %± SD:
0.6 ± 0.3; n = 9). These findings agree with the trend revealed by
the preliminary analysis of cytocentrifuged samples stained with
TB reported in Table 2. Of note the density of tryptase-positive
cells in the endometriotic lesions (Supplementary Figure S1
and Supplementary Table S2) is comparabe with those reported
in the literature (Konno et al., 2003; Kempuraj et al., 2004;
Sugamata et al., 2005; Anaf et al., 2006; Kirchhoff et al., 2012;
Paula et al., 2015).
Peritoneal Fluid Characterization of
Soluble Mediators
There were no significant differences (p = 0.572) between the
protein concentration (as measured by the Bradford method) of
the PF between cases (mean ± SD: 1.19 ± 0.04 mg/mL) and
controls (mean± SD: 1.21± 0.06 mg/mL) (Table 3).
The PF study group (EMS) is characterized by a statistically
significant (p = 0.031) increased tryptase enzymatic activity
(mean ± SD: 4.2 ± 1.2) compared to the control group
FIGURE 3 | Sperm viability (mean % + SE) after swim-up (T0), after 3 and
24 h incubation in HTF medium (HTFM), peritoneal fluid from women with
endometriosis (PF-EMS) and from controls (PF-C). T0 vs. HTFM 3 h:
p = 0.9271; T0 vs. PF-EMS 3 h: p = 0.2077; T0 vs. PF-C 3 h p = 0.7543; T0
vs. HFTM 24 p = 0.0083; T0 vs. PF-EMS 24 h p = 0.0386; T0 vs. PF-C 24 h
p = 0.0061. ∗p < 0.05; ∗∗p < 0.01.
(mean ± SD: 3.0 ± 0.8) (Table 3). The concentration of tryptase
expressed as ng/mL of PF is also shown in Table 3. Similarly
to what was found for the enzymatic activity of the tryptase in
the PF, the study group was characterized by a concentration of
tryptase (mean ± SD: 16.4 ± 3.9) significantly higher (p = 0.023)
than that of the control group (mean± SD: 12.3± 2.3).
Results reported in Table 3 show that there were no
statistically significant differences between the peritoneal levels
of β-hexosaminidase enzymatic activity in the two groups
(p = 0.408). This result is not surprising, since this enzyme is not
MC-specific as tryptase is.
TABLE 3 | Biochemical characterization of the peritoneal fluid in the study and
control group.
Control (C) Study (EMS) Statistical
Group (n = 9) Group (n = 11) analysis
Protein concentration
(mg/ml) Mean ± SD
1.21 ± 0.04 1.19 ± 0.06 ns
β-hexosaminidase
enzyme activity
(AU/ml) Mean ± SD








12.3 ± 2.3 16.4 ± 3.9 p = 0.023
Arbitrary units (AU) are expressed as: absorbance of 4-nitrophenol/ml for
β-hexosaminidase; absorbance of p-nitroaniline/ml, for Tryptase. For more details
see text. Statistical analysis: Student t-test, two tailed unpaired.
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FIGURE 4 | Total (A) and progressive (B) sperm motility (mean % ± SE) after swim-up (T0 starting condition), after 3 and 24 h incubation in HTF medium alone
(HTFM), peritoneal fluid from women with endometriosis (PF-EMS) and from controls (PF-C). In (A) T0 vs. HTFM 3 h: p = 0.4617; T0 vs. PF-EMS 3 h: p = 0.0642; T0
vs. PF-C 3 h p = 0.0058; T0 vs. HFTM 24 h p < 0.0001; T0 vs. PF-EMS 24 h p < 0.0001; T0 vs. PF-C 24 h < 0.0001. In (B) T0 vs. HTFM 3 h: p = 0.0133; T0 vs.
PF-EMS 3 h: p = 0.0043; T0 vs. PF-C 3 h p = 0.0027; T0 vs. HFTM 24 p < 0.0001; T0 vs. PF-EMS 24 h p < 0.0001; T0 vs. PF-C 24 h p < 0.0001. In both figures
∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001 and ∗∗∗∗p < 0.0001.
Modulation of Human Sperm Function by
Peritoneal Fluid
Motility-enriched sperm samples (n = 19) were incubated
in HTFM containing 0.05% BSA or peritoneal fluid pools,
respectively, obtained by mixing equal volumes of fluid samples
taken from patients with endometriosis [PF-EMS (#11): final
tryptase concentration = 14.7 ng/mL] and those collected
from women endometriosis-free [PF-C (# 9): final tryptase
concentration = 11.1 ng/mL].
Total and progressive sperm motility (Figures 4A,B) was
significantly decreased in comparison with starting conditions
(T0) both after 3 and 24 h incubation period in all condition
tested (p < 0.05). Anyway, no significant differences were
observed when comparing total and progressive motility of
spermatozoa incubated for 3 or 24 h in either PF-C or PF-
EMS, to that of sperm incubated for the same period in
HTF medium alone.
SEM Analysis of LAD2-Sperm Interaction
The mast cell line LAD2 was incubated for 1 h at 37◦C
alone or with sperms (cells ratio: sperms = 1:3–5) in TyB
alone or supplemented with either 10% of peritoneal fluid of
study (PF-EMS) or control (PF-C) group. LAD2 cells-sperm
interaction was evaluated by scanning electron microscopy
(SEM) in samples prepared from two separate experiments.
When incubated for 1 h LAD2 cells and sperms frequently show
cell to cell adhesive interaction. This interaction is realized either
through the sperm head/midportion (HM) or the sperm tail
as previously described for macrophages (Blanco et al., 1992).
Figure 5 summarizes these types of interaction as monitored by
SEM analysis. Figure 5a represents the LAD2-sperm interaction
in the presence of PF-C. At least four tail-LAD2 interactions
are apparent with three LAD2, while only one head-LAD2
interaction can be seen (arrow). Conversely, in Figure 5b,
which is representative of LAD2-sperm interaction in the
presence of PF-EMS, two sperms in contact with one LAD2 are
visible (arrowhead).
With the purpose of evaluating in detail the extent of LAD2-
sperm interaction we analyzed more than 100 SEM fields and
scored the number of sperm-head/midportion (HM) and sperm-
tail interaction with LAD2. Table 4 shows the result of this
analysis. On average, the total sperm-interacting LAD2 (either
by HM or by tail) in the presence of PF-EMS accounted for
2.3 cells/field while the interacting cells in the presence of PF-
C were 1.3 (ns). The HM sperm-LAD2 interaction in PF-EMS
were significantly higher, accounting for 1.2 interactions/field
with respect to that observed in the presence of PF-C (0.7
interactions/field). The difference was statistically significant
with p < 0.05. Conversely the tail sperm-LAD interaction
was almost the same in either PF-EMS or PF-C and was not
further considered. Figure 5c shows two intimate adhesions
between sperm and LAD2 surface in the presence of PF-EM.
In both cases, extracellular secretion/degranulation can be seen,
as either massive extrusion (arrow in c) or single granule
secretion (inset in c).
Since degranulation is a reliable marker of MC activation,
we assayed cell culture supernatants for the presence of β-hexo
(β-hexo), an enzyme located in MC granules.
LAD2 Degranulation Induced by Sperm
Interaction
β-hexo is used as a typical marker of mast cell degranulation
in vitro. Table 5 shows that the amounts of β -hexo secreted
by LAD2 cells is significantly higher after the addition of motile
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FIGURE 5 | LAD2-sperm interaction evaluated by SEM analysis. (a)
represents the LAD2-sperm interaction in the presence of PF-C. At least four
tail-LAD interactions are apparent with three LAD, while only one head-LAD
interaction can be seen (arrow). (b) is representative of LAD2-sperm
interaction in the presence of PF-EMS, two sperms in contact with one LAD2
are visible (arrow). (c) and inset shows two intimate HM interactions between
sperm and LAD surface in the presence of PF-EMS. In both cases,
extracellular secretion can be seen, as either massive extrusion [arrow in (c)]
or single granule secretion [inset in (c)]. Magnification bars: in (a,b) = 3 µm, in
(c) = 1 µm and in the inset of (c) = 3 µm.
sperm to resting cells (mean %± SD: 6.3± 0.7 n = 3 vs. 4.2± 0.9
n = 5 p = 0.0119) (Table 5).
LAD2 can release also tryptase in the extracellular medium
and, likewise to β-hexo, the amount of tryptase secreted by LAD2
cells is higher after the addition of motile sperms to resting cells
(% tryptase release, mean of two experiments: 26.3 vs. 15.2, n = 2).
Anyway we choose β -hexo activity as LAD2-degranulation
marker in the following experiments, since tryptase activity
in PF was too high and could mask and underestimate the
secretory response of LAD2. LAD2 co-incubated (30 min) with
human motile sperms in the presence of PF (10%) pool from
controls or PF pool from EMS patients were evaluated for β
-hexo release (Table 5). While the extent of secretion didn’t
change significantly in the presence of PF-C with respect to
the presence of sperm only (mean % ± SD: 7.0 ± 2.0 n = 3
and 6.3 ± 0.7 n = 3 – p = 0.5954), it is significantly increased
in the presence of PF-EMS (mean % ± SD: 16.67 ± 2.50
n = 3 vs. 6.30 ± 0.66 n = 3– p < 0.0001) and, interestingly,
resulted comparable to the secretion induced by 48/80, a potent
mast cell-secretagogue, reported for comparison as a positive
control (Table 5). However, considering that the ratio between
the percent of LAD2 degranulation (% degranulation) and the
percent of LAD2 interacting with head-MD of sperms (% HM
interacting LAD2) (Supplementary Table S1) is almost the same
either in the presence of PF-EMS or PF-CTRL), it appears that
the higher sperm-induced LAD2 degranulation in PF- is almost
completely dependent on the HM event number.
DISCUSSION
Endometriosis (EMS) is a common disease among women of
reproductive age and is frequently associated with infertility
(Gupta et al., 2008). However, the pathogenesis of this disease is
still unknown, so that in several cases the available treatments for
symptoms are ineffective (Zito et al., 2014). Increasing evidence
supports an involvement of MC either in the inflammatory
process of EMS (Kirchhoff et al., 2012) and infertility (Meineke
et al., 2000; Weidinger et al., 2003, 2005; Roaiah et al., 2007; Haidl
et al., 2011; Menzies et al., 2011). MC are normal constituents
of the human myometrium and endometrium and are present
in the female genital tract (Sivridis et al., 2001; Hunt and Lynn,
2002). In particular, MC was demonstrated in the oviduct wall
(Hunt and Lynn, 2002) and under the lining epithelium of human
Fallopian tubes (Weidinger et al., 2003). Endometriotic lesions
are characterized by high numbers of degranulated MC (Konno
et al., 2003; Kempuraj et al., 2004; Sugamata et al., 2005; Anaf
et al., 2006; Kirchhoff et al., 2012; Paula et al., 2015). Mast cells
leave evidence, a “fingerprint,” of their participation in acute
clinical events, that is an elevation in levels of their secreted
mediators/metabolites. Of these, tryptase is currently one of the
diagnostic criteria for mast cell activation (Butterfield et al., 2018).
While clearly showing MC in the female genital tract, it remains
unclear whether or not tryptase from the tubal or uterine MC can
reach the lumina of these organs. Up to now the concentration
of tryptase in the uterus or Fallopian tubal fluid has not been
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TABLE 4 | Quantitative and qualitative analysis of LAD2-sperm interaction.
Field LAD2 LAD2/Field InteractingLAD2/ HM interactions/ Tail interactions/
scored (n) scored (n) (mean ± SE) field (mean ± SE) field (mean ± SE) field (mean ± SE)
PF-C 100 719 8.8 ± 0.50 1.3 ± 0.3 0.7 ± 0.2 1.2 ± 0.3
PF-EMS 120 646 7.3 ± 0.5 2.3 ± 0.3 1.2 ± 0.1 1.3 ± 0.2
Statistical analysis ns p < 0.05 ns
HM, head/midportion. Values are the mean ± SE, obtained from the evaluation of two different experiments. Statistical Analysis: Student t-test, two tails unpaired.
reported. The presence of tryptase in the female genital tract have
been only supposed from its presence in the follicular fluid. In this
study, we characterized the peritoneal environment associated
with endometriosis and infertility (comparing it to control, fertile
and endometriosis-free conditions), as regards the MC cellular
component and its main product: tryptase.
Our data quantify, for the first time, the presence of an
increased number of tryptase-positive cells/MC in the peritoneal
fluid of infertile EMS affected women. We also found a
significantly reduced number of blood basophils in EMS-group.
These cells share with MC the hematopoietic precursor (Yu
et al., 2018) and many other features (Marone et al., 2005) and
may in principle be involved in EMS pathogenesis, as well. We
could speculate a mobilization of basophils from the circulation
to the peritoneal cavity. However, this contribution is difficult
to evaluate since standard staining techniques are not able to
distinguish MC from basophilic granulocytes. Anyway, since
normal blood basophils express only trace amounts of tryptase
(Li et al., 1998; Samorapoompichit et al., 2001), which has been
the main tool and target of our research, and the main diagnostic
criteria for identifying mast cell (Butterfield et al., 2018), their
contribution was not further considered and should deserves
a dedicated research. The increase of MC in the peritoneal
environment we found does not prove by itself that MC are
involved in the EMS pathogenesis, but is in agreement with the
increment of tissue MC population in EMS condition described
by other authors (Konno et al., 2003; Kempuraj et al., 2004;
Sugamata et al., 2005; Anaf et al., 2006; Kirchhoff et al., 2012;
Paula et al., 2015).
TABLE 5 | Secretory response of LAD2 induced by sperm interaction.
Degranulation:
% β-hexo release
(mean ± SD) n Statistical analysis
Resting LAD2 4.2 ± 0.9 5
LAD2+sperm 6.3 ± 0.7 3 [1] vs. [2]: p = 0,0119
LAD2+sperm in PF-C 7.0 ± 2.0 3 [2] vs. [3]: ns
[4] vs. [3]: p = 0,0007
LAD2+sperm in PF-EMS 16.7 ± 2.5 3 [2] vs. [4]: p < 0.0001
LAD2+48/80 17.4 ± 2.1 3 [1] vs. [5]: p < 0.0001
Percent of release of β-hexo. form LAD2 cells alone (Resting LAD2) and challenged
(30 min) with sperm in the absence (in TyB) and the presence of pools of PF from
EMS (PF-EMS) and control subjects (PF-C). The positive control was obtained
by cell stimulation with compound 48/80. β-hexo, β-hexosaminidase. Values are
expressed as percentage of enzymatical activity released, taken the total activity
of LAD2- βhexo as 100%. For more details see text. Statistical analysis: Dunn’s
post hoc was used to individuate group difference.
Accordingly, the peritoneal fluid in infertile-EMS conditions
was characterized by higher levels of enzymatically active
tryptase, the main MC product. Higher EMS peritoneal fluid
levels of tryptase could be ascribed not only to the increment of
peritoneal MC population but also to that of tissue population.
These cells are responsive to many different receptors and can
be activated by various kind of stimuli (Redegeld et al., 2018).
Now, the physical interaction with sperms should be added to
the list. The released mediators could reach in the peritoneum
a high level which in principle could affect sperm motility and
fertility as previously suggested. Human recombinant tryptase
has been shown to inhibit sperm motility in vitro (Weidinger
et al., 2003, 2005) and accordingly tryptase has been supposed
as a yet unrecognized factor capable of influencing sperm
fertilizing ability. Anyway, up to now tryptase levels have been
evaluated only in human seminal plasma of andrological patients
(4.18 ± 1.95 ng/mL) and in human follicular fluid (ranging
from 1.60 to 3.73 ng/mL), where they results far below the
lower level capable of inhibit sperm motility in vitro (10 ng/mL).
Accordingly, seminal fluid’s levels of tryptase were not correlated
to sperm motility (Weidinger et al., 2003).
Infertility is a condition associated with EMS and the effect of
peritoneal fluid associated with the condition of endometriosis
on sperm motility has been a long controversial topic: some
experimental evidence support a decrease in sperm motility
in this environment (Aeby et al., 1996; Oral et al., 1996; Liu
et al., 2000; Luo et al., 2008; Xu et al., 2008), while other
authors report no effect (Chen et al., 1997; Sharma et al., 1999;
Munuce et al., 2003).
Interestingly, the concentration of enzimatically active
tryptase that we found in the peritoneal fluid of both study (EMS:
16.4 ± 3.9 ng/mL) and control group (C: 12.3 ± 2.3 ng/mL)
was higher than those reported in human seminal plasma of
andrological patients and human follicular fluid, and higher than
the minimum concentration capable of inhibiting in vitro sperm
motility (Weidinger et al., 2003). In spite of this we didn’t find
any differences when analyzing sperm viability and motility (total
and progressive) in the presence of tryptase enriched peritoneal
fluid associated with endometriosis and infertility with respect
to control, fertile and endometriosis-free conditions (nor to
control medium alone), both in short and long term incubation.
Our data are in agreement with previous reports showing the
absence of any effect of EMS peritoneal fluid on sperm motility
(Chen et al., 1997; Sharma et al., 1999; Munuce et al., 2003) and
suggest that tryptase levels, able of inhibiting sperm motility
in vitro, are ineffective in the peritoneal environment. Anyway
we cannot exclude that tryptase (or other still unrecognized MC
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mediators) could modulate other sperm function in vivo, eg.
acrosome reaction (Arumugam, 1994; Munuce et al., 2003) or
sperm-oocyte interaction (Aeby et al., 1996; Wong et al., 2001;
Caille et al., 2012). While the present report was focused on
sperm motility in the presence of EMS-PF, the possible effects of
tryptase on sperm functions, will be the subject of future research.
Furthermore, Cincik and Sezen previously reported that
the presence of MC in semen, by itself negatively affects
sperm motility (Cincik and Sezen, 2003). Accordingly, since
the number of tryptase-positive cells/MC increases in the
peritoneal fluid of infertile EMS affected women we decided
to investigate the possible interaction between these cells and
sperm in the peritoneal environment. We co-incubated mast
cells (cell line LAD2) and sperms in a pool of PF (10%
v/v) obtained from infertile women with EMS or from fertile
endometriosis-free controls. Sperm was shown to interact more
with LAD2 in the presence of PF-EMS. Furthermore LAD2-
sperm interaction was shown to induce a secretory response
from LAD2 cells (by morphological and secretory evaluations),
which was significantly higher in EMS conditions. We suggest
that this secretory response could contribute to increase the level
of tryptase present in PF-EMS.
CONCLUSION
In conclusion, on the basis of our findings it appears unlikely that
tryptase enriched peritoneal fluid could affect sperm motility.
Anyway the present study presents some reasons for caution,
as follows:
– The sample size was limited. A broader study concerning
different stages of endometriosis would increase the
value of our results.
– Human resident peritoneal mast cells are not readily
purified. To overcome this limitation in studying in human
beings the MC-sperm interaction, we used the most
differentiated human mast cells line available, endowed
with a high content of tryptase.
– The sperm parameters analyzed were limited to viability
and motility, so we cannot exclude that tryptase (or other
still unrecognized MC mediators) could modulate other
sperm functions in vivo, contributing to the infertility
associated with endometriosis.
The novelty reported in this paper is that the presence of a
tryptase rich PF can stimulate the sperm-mast cell interaction
and induce degranulation from these cells. However, even if
tryptase-positive cells are present in a higher percentage in
the PF-EMS, they remain quantitatively underrepresented, and
therefore their strong interaction with the sperm in the EMS
conditions couldn’t be enough to affect sperm function. We
think that this strong physical and functional mast cell-sperm
interaction could be more effective in the male genital tract
where MC mediated negative effects on sperm functions has been
reported but not clarified so far and require further investigation
(Agarwal et al., 1987; Hashimoto et al., 1988; Nagai et al., 1992;
Hussein et al., 2005; El-Karaksy et al., 2007; Haidl et al., 2011;
Menzies et al., 2011; Windschüttl et al., 2014) One potential
benefit to assisted reproductive clinics could derive from
targeting mast cells - sperm interaction to treat male infertility
due to testicular pathologies associated with inflammation and
germ cell loss, as recently suggested (Mayerhofer et al., 2018).
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